1608 WALNUT ST STE 1600 PHILADELPHIA, PA 19103 Get Directions
1608 WALNUT ST STE 1600 PHILADELPHIA, PA 19103 Get Directions
ProSolus Pharmaceuticals LP targets opportunities to formulate high barrier to entry generic Transdermal Drug Delivery systems (TDDs), with a strategic focus on generic ANDA and 505(b)(2) applications. ProSolus develops transdermal products at our state of the art laboratory as well as in-license TDDs that meet strict criteria. We have strategic alliances to provide pilot, clinical supply and commercial volumes to the market providing product under strict cGMP and as required DEA compliance. Our strategic partners have excellent FDA track records with no 483's over the past decade of inspections.
Our Goals:
Formulate, Develop, and Out-license TDDs in the U. S. and Internationally.
Provide resources and technical support through commercialization.
Enter into Agreements on a cost/profit sharing basis to commercialize TDDs.
Offer Fee for Service development of TDDs identified by ProSolus.
Collaborate to provide full or supplemental services to assure speed to market.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.